BCR and acute lymphoblastic leukemia: Moreover, pre-B ALL and Ph+ ALL cells (including the multi-drug-resistant Ph+ ALL phenotype carrying mutant BCR-ABL1T315I) were significantly more sensitive to treatment than mature B-cell lymphoma or MM cells.